Aida Pharmaceuticals, Inc.
AIDA · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $30,510 | $46,715 | $43,442 | $11,220 |
| - Cash | $8,399 | $6,117 | $3,129 | $0 |
| + Debt | $33,368 | $29,554 | $25,168 | $0 |
| Enterprise Value | $55,479 | $70,152 | $65,480 | $11,220 |
| Revenue | $29,204 | $29,643 | $24,527 | $15,645 |
| % Growth | -1.5% | 20.9% | 56.8% | – |
| Gross Profit | $14,693 | $15,562 | $16,194 | $11,023 |
| % Margin | 50.3% | 52.5% | 66% | 70.5% |
| EBITDA | $7,320 | $6,016 | $3,812 | $3,625 |
| % Margin | 25.1% | 20.3% | 15.5% | 23.2% |
| Net Income | $2,740 | $1,454 | $1,468 | $1,635 |
| % Margin | 9.4% | 4.9% | 6% | 10.5% |
| EPS Diluted | 0.1 | 0.06 | 0.06 | 0.07 |
| % Growth | 66.7% | 0% | -14.2% | – |
| Operating Cash Flow | $8,392 | $2,660 | $6,121 | – |
| Capital Expenditures | -$3,613 | -$2,968 | -$700 | – |
| Free Cash Flow | $4,778 | -$308 | $5,420 | – |